| 摘要: |
| ［摘要］ 新生儿呼吸窘迫综合征（NRDS）是由肺表面活性物质（PS）缺乏而引起的新生儿早期死亡的危重疾病。近年来对NRDS的治疗取得显著进展，该文概述了NRDS的PS替代疗法、氧疗和体外膜氧合的治疗进展。 |
| 关键词: 新生儿呼吸窘迫综合征 肺表面活性物质 氧疗 液体通气 体外膜氧合 |
| DOI：10.3969/j.issn.1674-3806.2014.11.32 |
| 分类号:R 722.1 |
| 基金项目:广西钦州市科研与技术开发计划项目（编号：20120302） |
|
| Progress in the treatment of neonatal respiratory distress syndrome |
|
HUANG Guo-sheng, TAN Yi
|
|
Department of Pediatrics, Women and Children′s Health Hospital of Qinzhou City, Guangxi 535099，China
|
| Abstract: |
| ［Abstract］ Neonatal respiratory distress syndrome (NRDS) is a critical illness that caused early neonatal death because the lack of pulmonary surfactant(PS).Remarkable progress in the treatment of NRDS has been made in recent years. This paper summarized the progress in treatment of NRDS with PS replacement therapy, oxygen therapy and extracorporeal membrane oxygenation. |
| Key words: Neonatal respiratory distress syndrome(NRDS) Pulmonary surfactant Oxygen therapy Liquid ventilation Extracorporeal membrane oxygenation |
